Nuclear medicine innovation at the forefront of new partnership between South West Exposures and the Canadian Nuclear Isotope Council

Innovative start-up South West Exposures (SWE) is the latest addition to a growing list of members joining the Canadian Nuclear Isotope Council, an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research groups.

There is widespread awareness of the use of radiation and isotopes in medicine, particularly for diagnosis and therapy of various medical conditions. Medical isotopes are very important, particularly for diagnostic purposes in oncology, cardiology and neurology. Therapeutic applications, however, are quickly growing in use and will be a potential driver of market demand in the coming years.

In therapeutics, by linking the correct medical isotope to a suitable tracer, the nuclear medicine specialist is able to deliver the medical isotopes to the correct site in the body. This significantly minimizes the damage to healthy cells while effectively killing the diseased cells.

“Radioactive medications are rapidly becoming the gold-standard in both diagnosis & treatment of serious illnesses,” said Robert Kamen, Co-Founding President at CWE. “ As a technologist with 20-plus years of experience, I am particularly proud of Canada’s place in global radioisotope supply, which is why partnering with the CNIC to continue to advocate for Canada’s leadership position in this crucial sector is paramount.

“Together, SWE and the CNIC will enhance safe access to unique technologies, which will help Nuclear Medicine specialists dispense and administer high-quality care.”

In its latest report, the CNIC identified that guarding and supporting our nuclear knowledge is important to the majority of Canadians for both our health care and safety. In Canada all steps in the chain are present in order to perform our own research, but also to contribute to international developments and clinical trials.

“Canada is a leader in the fight against cancer and disease, but our work isn’t nearly done,” said James Scongack, Chair of the CNIC. “Now is the time to make a renewed commitment to finding new programs, and products like those produced by SWE to improve people’s lives.

“The clearest and widest-reaching benefits come from the enabling of lifesaving medical treatments by providing medical isotopes for patient use. Through collaboration with its partners, CNIC members enable the diagnosis and treatment of disease in fields as diverse as cardiology, oncology, and neurology.”

The Canadian Nuclear Isotope Council recognizes the opportunity presented by continued Canadian leadership in isotope development, which is why the CNIC serves as a voice in safeguarding the continued availability of isotopes, ensuring our public policies are risk-informed and science-based, and support the highest levels of public health and safety.

About South West Exposures

South West Exposures is a unique Canadian designer and fabricator of shielding solutions, dedicated to enhancing the handling and distribution of medical isotopes, improving efficiency and protection to the healthcare practitioner. SWE patent pending, disruptive and customizable designs optimize the safe transportation and administration of various theranostics agents, including high energy isotopes.

For more information, please contact:
Robert Kamen
Co-Founding President